insights_auto
Why is OCEA down 37,50%?
Dive Deeperchevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
US$0,00050
arrow_downward
-37,50%(-0,00030) 1D
14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCEA...
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
80,17 ພັນ
Avg. vol.
39,96 ພັນ
Volume
349,75 ພັນ
52-wk high
US$0,01
52-wk low
US$0,00
Beta
2,65
Shares outstanding
232,36 ລ້ານ
No. of employees
7
Open
US$0,00
High
US$0,00
Low
US$0,00
Mkt. cap
80,17 ພັນ
Avg. vol.
39,96 ພັນ
Volume
349,75 ພັນ
52-wk high
US$0,01
52-wk low
US$0,00
Beta
2,65
Shares outstanding
232,36 ລ້ານ
No. of employees
7
News stories
From web sources and news partners
GlobeNewswire
·
10 ນາທີກ່ອນ
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StreetInsider
·
11 ນາທີກ່ອນ
RedCloud faces Nasdaq delisting threat, appeals ruling to stay listed
Investing.com
·
4 ນາທີກ່ອນ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.09%
Seeking Alpha
·
2 ຊົ່ວໂມງກ່ອນ
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc